Xavier de Mollerat, Ph.D, discusses Invivofectamine™—RNAi In Vivo Delivery Reagent. watch video
The success of siRNA technology is dependent not only on the effectiveness of... read more
Stay updated on the latest technologies and news with Biocompare's newsletters (See samples here)
It’s not easy to find a molecule that specifically antagonizes each of the 518 kinases encoded in the human genome... read more